Evaluating the Frequency of Mole Checks by a Dermatologist and Correlated Variables in a Global Survey across 17 Countries: HELIOS Project
Year: 2024
Type: article
Study design: Observational Study
Abstract: Secondary prevention of skin cancer consists in early detection of malignant lesions through patients' mole self-examination and medical examination. The objective of this study was to assess the self-reported frequency of mole examination in a large, representative sample of the adult general population of 17 countries from all continents. Of a total of 17,001 participants, 4.8% had their moles checked by a dermatologist more than once a year, 11.3% once a year, 8.4% every 2-3 years, 12.4% once in a while, 10.3% once in lifetime, and 52.6% of participants had never performed a mole examination. Egypt was the country with the highest prevalence of people who performed a moles check more than once a year (15.9%), followed by Brazil and the USA. A higher frequency of mole checks was associated with sex (man vs woman), higher education, higher income, fair phototype, history of skin cancer, medical insurance, and sun-protective behaviours. Despite recommendations by health providers, it appears that the frequency of mole checks in the general population is still low. It is necessary for dermatologists to keep informing at-risk populations about the importance of moles check, with particular care regarding categories that less frequently adhere to secondary prevention measures.
Source: Acta Dermato Venereologica
Institutions: Henry Ford Health, Henry Ford Hospital, Inserm, Université Côte d'Azur, Centre Hospitalier Universitaire de Nice, Centre Méditerranéen de Médecine Moléculaire, National Skin Centre, Ajou University, Cheikh Anta Diop University, Nagoya City University, Universidad Autónoma de Nuevo León, Hospital Universitario Dr José Eleuterio Gonzalez, Hospital Clínic de Barcelona, Universidade de São Paulo, Air Force General Hospital PLA, People's Liberation Army Air Force, L'Oréal (France), Immunologie et Nouveaux Concepts en Immunothérapie, Nantes Université, Leibniz Institute of Environmental Medicine
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $1,725
OpenAlex ID: W4401820196
